{"id":"NCT01871558","sponsor":"Novartis Pharmaceuticals","briefTitle":"Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin","officialTitle":"Randomized, Open-label, SU-controlled Study of 24-week Duration to Compare Metformin/Vildagliptin + Basal Insulin Versus Metformin/SU + Basal Insulin in T2DM Patients Starting Basal Insulin After Failing Metformin/SU","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2013-06-06","resultsPosted":"2016-03-23","lastUpdate":"2016-04-21"},"enrollment":42,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus (T2DM)"],"interventions":[{"type":"DRUG","name":"Vildagliptin","otherNames":["Galvus"]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"sulfonylurea (SU)","otherNames":[]},{"type":"DRUG","name":"Basal Insulin","otherNames":[]}],"arms":[{"label":"SU+metformin + Basal Insulin","type":"ACTIVE_COMPARATOR"},{"label":"Metformin/vildagliptin + Basal Insulin","type":"EXPERIMENTAL"}],"summary":"To compare a therapeutic strategy combining vildagliptin+metformin + Basal Insulin versus SU+metformin + Basal Insulin on the incidence of hypoglycemic events over 24 weeks.","primaryOutcome":{"measure":"Percentage of Patients Who Reported at Least One Symptomatic Hypoglycemic Event During the 24 Week Randomized Period in Both Treatment Arms","timeFrame":"24 weeks","effectByArm":[{"arm":"Metformin/Vildagliptin + Basal Insulin","deltaMin":22.2,"sd":null},{"arm":"SU+Metformin + Basal Insulin","deltaMin":45,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.139"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":2},"locations":{"siteCount":19,"countries":["France"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Dyspepsia","Urinary tract infection","Conjunctival haemorrhage","Visual impairment","Fatigue"]}}